Selection and Optimization of a Mucosal Sampling Method for Application in Phase 1 Clinical Trials

被引：0

作者：

Bergin, P. J. ^{[1
]}

Langat, R. ^{[2
]}

Omosa-Manyoni, G. ^{[2
]}

Farah, B. ^{[2
]}

Bizimana, J. ^{[3
]}

Umvirigihozo, G. ^{[3
]}

Nyombayire, J. ^{[3
]}

Ouattara, G. ^{[2
]}

Ingabire, R. ^{[3
]}

Park, H. ^{[4
]}

Chetty, P. ^{[4
]}

Verlinde, C. ^{[4
]}

Laufer, D. ^{[4
]}

Cox, J. ^{[4
]}

Stevens, G. ^{[4
]}

Fast, P. ^{[4
]}

Gilmour, J. ^{[1
]}

Karita, E. ^{[3
]}

Anzala, O. ^{[2
]}

机构：

[1] Univ London Imperial Coll Sci Technol & Med, Int AIDS Vaccine Initiat, Human Immunol Lab, London, England

[2] Univ Nairobi, Kenya AIDS Vaccine Initiat, Nairobi, Kenya

[3] Project San Francisco, Kigali, Rwanda

[4] Int AIDS Vaccine Initiat, New York, NY USA

来源：

AIDS RESEARCH AND HUMAN RETROVIRUSES | 2013年 / 29卷 / 11期

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：A181 / A181

页数：1

共 50 条

[1] A standardization method to adjust for the effect of patient selection in phase II clinical trials
Mazumdar, M
Fazzari, M
Panageas, KS
[J]. STATISTICS IN MEDICINE, 2001, 20 (06) : 883 - 892
[2] A web application for optimal selection of adaptive designs in phase I oncology clinical trials
Chen, Sheau-Chiann
Shyr, Yu
[J]. TRIALS, 2017, 18
[3] Use of the experience sampling method in the context of clinical trials
Verhagen, Simone J. W.
Hasmi, Laila
Drukker, Marjan
van Os, J.
Delespaul, Philippe A. E. G.
[J]. EVIDENCE-BASED MENTAL HEALTH, 2016, 19 (03) : 86 - 89
[4] Phase 1 clinical trials
Jaillon, P
[J]. PRESSE MEDICALE, 2001, 30 (19): : 952 - 955
[5] The application of dried blood spot sampling in global clinical trials
van Amsterdam, Peter
Waldrop, Clare
[J]. BIOANALYSIS, 2010, 2 (11) : 1783 - 1786
[6] Application of Adaptive Sampling Method in Hull Form Optimization
Ouyang, Xuyu
Chang, Haichao
Liu, Zuyuan
Feng, Baiwei
Zhan, Chengsheng
Cheng, Xide
[J]. Shanghai Jiaotong Daxue Xuebao/Journal of Shanghai Jiaotong University, 2022, 56 (07): : 937 - 943
[7] Phase 1 clinical trials in oncology
Miller, MJ
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (23): : 2452 - 2452
[8] Phase 1 clinical trials and toxicity
不详
[J]. LANCET HAEMATOLOGY, 2017, 4 (04): : E147 - E147
[9] Feasibility of Mucosal Sampling in Low-risk Women in HIV/AIDS Vaccine Clinical Trials
Nyaoke, Borna
Perciani, Catia
Mureithi, Marianne W.
MacDonald, Kelly S.
Jaoko, Walter
[J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 2016, 32 : 308 - 308
[10] The use of next generation sequencing (NGS) to guide patient selection for phase 1 clinical trials
Miller, R. E.
Brown, N. F.
Speirs, A.
Shaw, H. M.
Adeleke, S.
Gougis, P.
Bennett, P.
Meyer, T.
Swanton, C.
Forster, M.
Kristeleit, R. S.
[J]. ANNALS OF ONCOLOGY, 2016, 27

← 1 2 3 4 5 →